Twist Bioscience Corp

Change company Symbol lookup

Select an option...

TWST Twist Bioscience Corp

MKSI MKS Instruments Inc

TPZ Tortoise Power and Energy Infrastructure Fund

NYC American Strategic Investment Co

MDV Modiv Inc

SBIG springbig Holdings Inc

KBNT Kubient Inc

FGF FG Financial Group Inc

NVNO enVVeno Medical Corp

BROGW Brooge Holdings Equity Warrants Expiring 20 Dec 2024 *W EXP 12/20/2024

Go

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist...(BusinessWire)

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the appointment of Robert Werner as chief accounting officer. (BusinessWire)

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the launch of a portfolio of RNA sequencing tools, which includes the...(BusinessWire)

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist...(BusinessWire)

--- Orders increased to $64.2M in 2QFY23; up 17% over 2QFY22 - --- Decisive Actions to Accelerate Path to Profitability - Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality...(BusinessWire)

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Aster Insights, a bioinformatics company with the most advanced, direct-patient...(BusinessWire)

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced a collaboration with Astellas Pharma Inc. (TSE: 4503, President and...(BusinessWire)

--Information about the offering available at AACR Annual Meeting 2023 Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today...(BusinessWire)

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will issue its financial results for the fiscal 2023 second...(BusinessWire)

The DNA Data Storage Alliance, a SNIA Technology Affiliate, formed in 2020 by Illumina, Inc. (NASDAQ: ILMN), Microsoft (Nasdaq: MSFT), Twist Bioscience Corporation (NASDAQ: TWST) and Western Digital (NASDAQ: WDC) to create and promote an...(BusinessWire)

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Twist Bioscience Corp (NASDAQ: TWST) on behalf of long-term stockholders following a class action complaint that was...(BusinessWire)

SAN DIEGO, CA / ACCESSWIRE / March 14, 2023 / The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in shares of Twist Bioscience Corporation (NASDAQ:TWST).Investors who purchased shares of Twist Bioscience...(Accesswire)

-- Tracey Mullen, MBA, to lead Twist Biopharma Solutions -- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced an...(BusinessWire)

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist...(BusinessWire)